BTK Inhibitor: Novartis: No Liver Toxicity Seen to Date.

Published Date: 06 May 2023

Novartis expressed cautious optimism that its anti-inflammatory drug candidate, remibrutinib, might avoid the side effects that have plagued competing products in the same drug class by saying no signs of liver damage had yet been observed in trials testing the drug.

Read Full News

Latest News

What to Tell Patients Worried About PFAS Exposure

PFAS exposure is widespread, but clinicians can help patients understand the main sources, potential health effects, and practical ways to reduce risk.

Cherry Angiomas Linked to Neurofibromatosis Type 1

People with neurofibromatosis type 1 often have cherry angiomas, an unrecognized vascular manifestation of NF1, a study indicates.

Cefazolin Matches Penicillins for MSSA Bacteremia

A randomized trial finds cefazolin offers similar efficacy and less acute kidney injury than cloxacillin or flucloxacillin in adults with bacteremia.

Luigi Mangione Admits Killing Insurance CEO, Pleads Guilty in Federal Case

Luigi Mangione admitted in court on Friday that he fatally shot health insurance executive Brian Thompson and pleaded guilty to two federal charges of stalking the CEO with...

AstraZeneca Suffers Another Setback as It Halts Volrustomig Lung Cancer Trial

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle Looks to Develop New Products to Serve Users Of Weight-loss Drugs

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

Todays Updates

Many Clinical Paths Are Open to NPs. Here’s Help in Picking

‘A strength of the nurse practitioner profession is its versatility,’ one expert says.

Nurses Speak Out on Burnout, Mandatory Overtime, and Burning the Candle at Both Ends

Emotionally drained, sleep-deprived, and skipping meals to keep up: what nurse leaders say needs to change to prevent burnout.

Most Family Physicians Struggle With After-Hours Admin Work

Most family physicians face heavy administrative burden, but improved electronic health records and staff support may help to ease some of the load.

'Just Bloating': Stop Dismissing This Common GI Complaint

Bloating is one of patients' most common gastrointestinal complaints. Dr Alicia Muratore kicks off this six-part series by asking why bloating is often treated as an afterthought.

S1 Episode 4: Urinary Tract Infections and Sexual Function

Drs Anne Lenore Ackerman and Rachel S. Rubin discuss urinary tract infections, sexual function, quality of life, and the importance of patient education.

Immunotherapy Promises New Era in Cancer Prevention

Prof David Kerr explores whether PD-1 inhibitors and targeted vaccines can regress polyps and prevent secondary cancers in Lynch syndrome.

HF Hospitalizations and Telehealth Coverage Parity Laws

State telehealth coverage parity laws require private insurers to cover outpatient telehealth visits increasing access for HF patients. This analysis examines whether this affected clinical outcomes.

Todays Updates

Many Clinical Paths Are Open to NPs. Here’s Help in Picking

‘A strength of the nurse practitioner profession is its versatility,’ one expert says.

Nurses Speak Out on Burnout, Mandatory Overtime, and Burning the Candle at Both Ends

Emotionally drained, sleep-deprived, and skipping meals to keep up: what nurse leaders say needs to change to prevent burnout.

Most Family Physicians Struggle With After-Hours Admin Work

Most family physicians face heavy administrative burden, but improved electronic health records and staff support may help to ease some of the load.

'Just Bloating': Stop Dismissing This Common GI Complaint

Bloating is one of patients' most common gastrointestinal complaints. Dr Alicia Muratore kicks off this six-part series by asking why bloating is often treated as an afterthought.

S1 Episode 4: Urinary Tract Infections and Sexual Function

Drs Anne Lenore Ackerman and Rachel S. Rubin discuss urinary tract infections, sexual function, quality of life, and the importance of patient education.

Immunotherapy Promises New Era in Cancer Prevention

Prof David Kerr explores whether PD-1 inhibitors and targeted vaccines can regress polyps and prevent secondary cancers in Lynch syndrome.

HF Hospitalizations and Telehealth Coverage Parity Laws

State telehealth coverage parity laws require private insurers to cover outpatient telehealth visits increasing access for HF patients. This analysis examines whether this affected clinical outcomes.

Latest News

PFAS exposure is widespread, but clinicians can help patients understand the main sources, potential health effects, and practical ways to reduce risk.

People with neurofibromatosis type 1 often have cherry angiomas, an unrecognized vascular manifestation of NF1, a study indicates.

A randomized trial finds cefazolin offers similar efficacy and less acute kidney injury than cloxacillin or flucloxacillin in adults with bacteremia.

Luigi Mangione admitted in court on Friday that he fatally shot health insurance executive Brian Thompson and pleaded guilty to two federal charges of stalking the CEO with...

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

News All Time

Alopecia in Transgender Patients: Management Strategies

Low-dose oral minoxidil ranks high as a first-line alopecia treatment option for transmasculine individuals and, especially in combination with spironolactone, for transfeminine patients.

Skin Cancer Prevention Gaps Seen in Indigenous Adults

A survey of American Indian/Alaska Native adults in South Dakota finds low sunscreen use and gaps in skin cancer risk perception and knowledge.

Wellness Peptides Are Trending: Are They Safe?

Growing interest in unapproved peptides is raising concerns about weak human evidence, uncertain product quality, self-administration, and poorly understood long-term safety.

Hemangiomas: Absence of One Feature May Rule Out Syndrome

A systematic review of patients with LUMBAR syndrome found that the anatomic midline was involved in all cases, raising the possibility that this is a diagnostic criterion.

Hyperinsulinemic Hypoglycemia: Looking Beyond Insulinoma?

A distinctive metabolic signature may identify rare insulin receptor disorders earlier, helping clinicians avoid unnecessary insulinoma investigations.

FDA Approves Replimune Skin Cancer Drug After Rejections

The accelerated approval follows FDA concerns about the single-arm evidence supporting the treatment.

TikTok Turns Isotretinoin Into a Beauty Trend

Social media has fueled new demand for isotretinoin, but the drug’s true value and its best-known risks remain defined by evidence, not influencer hype.

Manufacturer Files for Botox Approval for Jawline Contouring

After positive findings from phase 3 trials, Allergan Aesthetics submits sBLA to the FDA for onabotulinumtoxinA, to improve the appearance of the masseter muscle.

Combo Therapy May Clear Stubborn Warts Faster

Combining topical urea with carboxytherapy may help reduce lesion size more effectively and achieve faster clearance than urea alone in patients with treatment-resistant common warts.

Surgeons Warn of 'Regulatory Gap' in Cosmetic Surgery

Surgical royal colleges warn the government's delayed consultation leaves patients exposed to under-qualified practitioners.

Deucravacitinib Shows Sustained Efficacy and Safety in PsA

Deucravacitinib shows greater efficacy than placebo in adults with active psoriatic arthritis at week 16, with sustained benefits through week 52 and a well-tolerated safety profile.

CSCC Incidence, NMSC Mortality Rise in England

The incidence of keratinocyte cancer rose in England from 2013 to 2022, with a stabilising incidence of BCC, an increasing incidence of cutaneous squamous cell carcinoma, and rising NMSC mortality.

Methotrexate Continuation in Psoriatic Disease Differs by Sex

Dutch data highlight the importance of considering sex-specific differences in methotrexate drug survival when prescribing it to patients with psoriatic disease.

Lactate: An Alternative to pH in Fetal Blood Sampling?

Lactate and pH in fetal scalp blood samples show moderate inverse correlation, with a proposed lactate cutoff of ≥ 5.6 mmol/L demonstrating an optimal sensitivity-specificity balance.

Two Studies Evaluate RF Microneedling Adverse Event Reports

Fat loss is an often-reported complication following radiofrequency microneedling, two new studies show. But experts are pushing back on both the findings and a recent FDA warning.

Precursor Keratinocyte Lesions Increased in SLE

Patients with systemic lupus erythematosus have higher risks for actinic keratosis and squamous cell carcinoma in situ, in a patient registry analysis.

Recommended News For You

Novel biomarker has potential for predicting and treating skin cancer metastasis

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

The diamonds that could find cancer

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

New policy review highlights the importance of health-related quality of life in advanced cancer

Recommended Articles For You

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology 

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Functional Iron Reserve Screening Before Clinical Deficiency: Clinical Insights and Evidence-Based Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

New protein target discovered for childhood medulloblastomas

3.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

4.

Papillary thyroid cancer: New markers offer hope for tailored treatment

5.

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

1.

Precision Oncology: Tailoring Cancer Treatment for the Individual

2.

Genetic Screening: A Game Changer in Cancer Prevention

3.

A Visual Journey Through Penile Cancer: Examining the Impact of Photos

4.

The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy

5.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

2.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

4.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot